MetLife, Inc. $MET Shares Bought by Victory Capital Management Inc.

Victory Capital Management Inc. lifted its stake in shares of MetLife, Inc. (NYSE:MET) by 40.9% during the third quarter, Holdings Channel reports. The firm owned 386,782 shares of the financial services provider’s stock after buying an additional 112,270 shares during the period. Victory Capital Management Inc.’s holdings in MetLife were worth $31,859,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Norges Bank bought a new position in MetLife during the 2nd quarter worth $756,104,000. Vanguard Group Inc. boosted its holdings in shares of MetLife by 13.3% during the third quarter. Vanguard Group Inc. now owns 64,749,521 shares of the financial services provider’s stock valued at $5,333,418,000 after acquiring an additional 7,578,199 shares during the period. ABN AMRO Bank N.V. acquired a new position in shares of MetLife during the second quarter valued at $178,669,000. Amundi grew its position in shares of MetLife by 40.2% during the second quarter. Amundi now owns 4,507,362 shares of the financial services provider’s stock worth $361,265,000 after acquiring an additional 1,292,107 shares during the last quarter. Finally, Man Group plc increased its holdings in shares of MetLife by 325.5% in the 2nd quarter. Man Group plc now owns 1,344,551 shares of the financial services provider’s stock worth $108,129,000 after acquiring an additional 1,028,554 shares during the period. Institutional investors and hedge funds own 94.99% of the company’s stock.

MetLife Trading Down 1.5%

Shares of MetLife stock opened at $71.83 on Monday. The business has a fifty day simple moving average of $77.20 and a 200-day simple moving average of $78.72. MetLife, Inc. has a fifty-two week low of $65.21 and a fifty-two week high of $85.00. The firm has a market cap of $46.84 billion, a price-to-earnings ratio of 15.28, a price-to-earnings-growth ratio of 0.66 and a beta of 0.76. The company has a quick ratio of 0.20, a current ratio of 0.20 and a debt-to-equity ratio of 0.52.

MetLife (NYSE:MET) last issued its quarterly earnings results on Wednesday, February 4th. The financial services provider reported $2.49 earnings per share for the quarter, beating analysts’ consensus estimates of $2.34 by $0.15. MetLife had a net margin of 4.38% and a return on equity of 21.81%. The company had revenue of $52.44 billion during the quarter, compared to the consensus estimate of $31.43 billion. During the same period in the prior year, the company earned $2.08 EPS. MetLife’s revenue was up 27.6% on a year-over-year basis. On average, equities analysts forecast that MetLife, Inc. will post 9.65 EPS for the current fiscal year.

MetLife Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 10th. Investors of record on Tuesday, February 3rd will be issued a dividend of $0.5675 per share. This represents a $2.27 dividend on an annualized basis and a yield of 3.2%. The ex-dividend date is Tuesday, February 3rd. MetLife’s dividend payout ratio (DPR) is presently 48.30%.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the stock. Keefe, Bruyette & Woods reduced their target price on shares of MetLife from $92.00 to $90.00 and set an “outperform” rating for the company in a research note on Tuesday, November 11th. Wells Fargo & Company cut their price target on MetLife from $97.00 to $93.00 and set an “overweight” rating on the stock in a report on Wednesday, February 25th. Mizuho set a $100.00 price objective on MetLife in a research report on Thursday, February 12th. Evercore set a $95.00 target price on MetLife in a research note on Tuesday, February 10th. Finally, Weiss Ratings upgraded MetLife from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Friday, February 20th. Two analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $94.18.

MetLife News Roundup

Here are the key news stories impacting MetLife this week:

• Positive Sentiment: MetLife confirmed its previously announced Q1 2026 dividend on its Series A floating-rate preferred shares, $0.31501229 per share, signaling consistency in capital returns for preferred holders and helping support yield-sensitive investors. Article Title
• Positive Sentiment: MetLife and partner Crow Holdings completed the sale/trade of 210 multifamily units in Tampa — an example of active portfolio management that can free capital or crystallize gains from real-estate holdings. Article Title
• Neutral Sentiment: MetLife GCC leased ~75,000 sq ft in Noida’s Oxygen Business Park — a regional expansion/lease that speaks to business presence in India but is unlikely to move the stock materially in the near term. Article Title
• Neutral Sentiment: High-profile events at MetLife Stadium (temporary renaming/World Cup hosting coverage, ticket guides) increase brand visibility and venue revenue potential, but these items are peripheral to core insurance fundamentals. Article Title
• Neutral Sentiment: A recent piece comparing MetLife’s stock performance to peers provides context for relative valuation and momentum; useful for investors but not a direct catalyst. Article Title
• Negative Sentiment: Morgan Stanley published a pessimistic forecast for MET, which likely contributed to selling pressure and the intraday decline — analyst downgrades/price-target cuts are common drivers of short-term stock weakness. Article Title

About MetLife

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.